| Literature DB >> 35448540 |
Asha Perera1, Catherine Soos1,2, Karen Machin3.
Abstract
Human-induced environmental changes that act as long-term stressors pose significant impacts on wildlife health. Energy required for maintenance or other functions may be re-routed towards coping with stressors, ultimately resulting in fluctuations in metabolite levels associated with energy metabolism. While metabolomics approaches are used increasingly to study environmental stressors, its use in studying stress in birds is in its infancy. We implanted captive lesser scaup (Aythya affinis) with either a biodegradable corticosterone (CORT) pellet to mimic the effects of a prolonged stressor or a placebo pellet. 1D 1H nuclear magnetic resonance (NMR) spectroscopy was performed on serum samples collected over 20 days after implant surgery. We hypothesized that CORT pellet-induced physiological stress would alter energy metabolism and result in distinct metabolite profiles in ducks compared with placebo (control). Quantitative targeted metabolite analysis revealed that metabolites related to energy metabolism: glucose, formate, lactate, glutamine, 3-hydroxybutyrate, ethanolamine, indole-3- acetate, and threonine differentiated ducks with higher circulatory CORT from controls on day 2. These metabolites function as substrates or intermediates in metabolic pathways related to energy production affected by elevated serum CORT. The use of metabolomics shows promise as a novel tool to identify and characterize physiological responses to stressors in wild birds.Entities:
Keywords: NMR spectroscopy; corticosterone; energy metabolism; hormone implants; lesser scaup; metabolomics; stress physiology
Year: 2022 PMID: 35448540 PMCID: PMC9030486 DOI: 10.3390/metabo12040353
Source DB: PubMed Journal: Metabolites ISSN: 2218-1989
Figure 1Serum CORT levels (mean ± SEM) before (D0), during (D2, D4), and after (D7, D10, D20) the active-pellet period from lesser scaup (Aythya affinis) that received either a 10-day slow-release cholesterol-based biodegradable CORT pellet (CORT) or placebo pellet that did not contain any hormone (control) on D0. Sample sizes are stated on each error bar. The asterisk (*) denotes statistical significance at p < 0.05.
Chemical shift and multiplicity of the metabolites (putatively annotated compounds using Chenomx NMR Suite 8.3 software) of 1D 1H NMR spectra of the polar extract of serum of lesser scaup (Aythya affinis) implanted with CORT or placebo pellets.
| No. | Compound Name | 1H NMR Chemical Shift (ppm) a, Multiplicity b |
|---|---|---|
| 1 | 2-Hydroxybutyrate | 0.88 t, 1.64 m, 1.73 m, 4.00 q |
| 2 | 3-Hydroxybutyrate | 1.19 d, 2.30 q, 2.40 q, 4.14 m |
| 3 | Acetate | 1.91 s |
| 4 | Acetoacetate | 2.27 s, 3.44 s |
| 5 | Alanine | 1.47 d, 3.78 q |
| 6 | Anserine | 2.65 m, 2.71 m, 3.05 q, 3.2 m, 3.78 s, 4.5q, 7.25 s, 7.92 s, 8.27 d |
| 7 | Arginine | 1.64 m, 1.70 m, 1.88 m, 1.92 m, 3.24 t, 3.76 t |
| 8 | Asparagine | 2.85 q, 2.94 q, 3.99 q, 6.91 s |
| 9 | Betaine | 3.26 s, 3.89 s |
| 10 | Carnitine | 2.41m, 3.21s, 3.42 m, 4.56 s |
| 11 | Choline | 3.19 s, 3.51 t, 4.06 s |
| 12 | Citrate | 2.53 d, 2.66 d |
| 13 | Creatine | 3.02 s, 3.92 s |
| 14 | Creatinine | 3.03 s, 4.05 s |
| 15 | Dimethylamine | 2.72 s |
| 16 | Ethanolamine | 3.13 t, 3.82 t |
| 17 | Formate | 8.44 s |
| 18 | Fumarate | 6.51 s |
| 19 | Glucose | 3.24 t, 3.40 m, 3.51 m, 3.70 m, 3.82 m, 3.89 d, 4.64 d, 5.22 d |
| 20 | Glutamate | 2.04 m, 2.12 m, 2.34 m, 3.75 m |
| 21 | Glutamine | 2.13 m, 2.44 m, 3.77 t, 6.87 s |
| 22 | Glycerol | 3.55 q, 3.65 q, 3.78 m |
| 23 | Glycine | 3.55 s |
| 24 | Glycolate | 3.93 s |
| 25 | Histamine | 3.00 t, 3.29 t, 7.14 s, 7.89 s |
| 26 | Histidine | 3.14 q, 3.24 q, 3.98 q, 7.10 s, 7.87 s |
| 27 | Imidazole | 7.31 s, 8.28 s |
| 28 | Indole-3-acetate | 3.64 s, 7.15 t, 7.24 t, 7.50 d, 7.62 d, 9.95 s |
| 29 | Isocitrate | 2.50 q, 2.55 q, 2.98 m, 4.05 d |
| 30 | Isoleucine | 0.93 t, 1.00 d, 1.25 m, 1.46 m, 1.97 m, 3.66 d |
| 31 | Lactate | 1.32 d, 4.10 q |
| 32 | Leucine | 0.95 t, 1.70 m, 3.73 q |
| 33 | Methionine | 2.10 t, 2.13 s, 2.19 m, 2.63 t, 3.85 q |
| 34 | Phenylalanine | 3.12 q, 3.28 q, 3.99 q, 7.32 d, 7.37 t, 7.42 t |
| 35 | Proline | 1.96 m, 2.02 m, 2.06 m, 2.34 m, 3.32 m, 3.42 m, 4.12 q |
| 36 | Pyruvate | 2.36 s |
| 37 | Sarcosine | 2.7 s, 3.60 s |
| 38 | Serine | 3.84 q, 3.94 q, 3.98 q |
| 39 | Succinate | 2.39 s |
| 40 | Taurine | 3.25 t, 3.42 t |
| 41 | Threonine | 1.32 d, 3.58 d, 4.25 m |
| 42 | Trimethylamine N-oxide | 3.25 s |
| 43 | Tryptophan | 3.30q, 3.48 q, 4.05 q, 7.19 t, 7.27 t, 7.32 s, 7.53 d, 7.72 d |
| 44 | Tyrosine | 3.04 q, 3.19 q, 3.93 q, 6.89 d, 7.18 d |
| 45 | Uracil | 5.80 d, 7.53 d |
| 46 | Valine | 0.98d, 1.03 d, 2.26 m, 3.60 d |
| 47 | Myo-inositol | 3.27 t, 3.53 q, 3.62 t, 4.06 t |
a The NMR spectral position and number of chemical shifts of a compound determine the chemical structure. b Multiplicity is related to the number of hydrogens located in the neighbouring carbon in the chemical structure of a compound. s, singlet; d, doublet; t, triplet; q, quadruplet; m, multiplet.
Figure 2Principal component analysis (PCA) score plots of serum metabolites of lesser scaup (Aythya affinis) using data from before (D0), during (D2, D4), and after (D7, D10, D20) the active period of the implant. Pink and blue ellipses represent the 95% confidence region for CORT (treatment) and control, respectively. Overlapping 95% confidence regions indicate similarity between metabolite profiles in the two groups The separation of 95% confidence regions into clusters indicates a notable difference between metabolite profiles (D2). The percentage of variability explained under each principal component is shown within parenthesis on the x- and y-axes. Sample sizes on D0, D2, D4, D7, D10, and D20 were 28, 26, 31, 31, 28, and 28, respectively.
Figure 3Partial least squares discriminant analysis (PLS-DA) scores plot (a) and corresponding variable importance in projection (VIP) score plot for D2 for component 1 (b) on D2 for serum of lesser scaup (Aythya affinis) that received either a CORT pellet (CORT) or a placebo (control). Numbers in parenthesis in axes of the PLS-DA score plot indicate the percentage of the variance explained by a corresponding component. In the VIP plot, metabolites with a VIP score > 1 are significant (i.e., VIP metabolites). The coloured boxes to the right of the VIP plot indicate which group had higher (red) vs. lower (green) levels of each metabolite compared to the other group.
Mean and standard error mean (SE) for concentrations (mM) for serum polar metabolites of lesser scaup (Aythya affinis) that were identified to have variable importance in projection (VIP) score > 1, using PLS-DA modeling for D2.
| VIP Metabolite (D2) | CORT | Control |
|
| ||
|---|---|---|---|---|---|---|
| Mean (mM) | SE | Mean (mM) | SE | |||
| 3-Hydroxybutyrate | 0.09 | 0.01 | 0.16 | 0.02 | −4.07 | <0.01 |
| Ethanolamine | 0.18 | 0.02 | 0.35 | 0.03 | −2.14 | 0.04 |
| Formate | 0.48 | 0.08 | 0.16 | 0.21 | 4.81 | <0.01 |
| Glucose | 3.29 | 0.29 | 2.53 | 0.19 | 3.26 | <0.01 |
| Glutamine | 0.24 | 0.04 | 0.15 | 0.10 | 2.79 | 0.01 |
| Indole-3-acetate | 0.06 | 0.01 | 0.12 | 0.02 | −2.69 | 0.01 |
| Lactate | 2.83 | 0.22 | 2.48 | 0.14 | 1.78 | 0.04 |
| Threonine | 0.14 | 0.01 | 0.18 | 0.02 | −3.81 | <0.01 |
a,bt and p correspond to the independent t-test results for mean comparison between the groups that received either a CORT pellet (CORT) or a placebo (Control), respectively. Statistical significance was set at p < 0.05.
Figure 41D 600 MHz 1H NMR spectra from serum collected on D2 from lesser scaup (Aythya affinis) that received either a (A) 10-day slow-release cholesterol-based biodegradable CORT pellet (CORT) or a (B) placebo pellet. Same y-scale is used for both spectra. Metabolites with a significant corresponding variable importance in projection (VIP) score are shown: glucose (1), formate (2), lactate (3), 4-ethanolamine (4), 3-hydroxybutyrate (5), glutamine (6). Peaks of indole-3-acetate and threonine are not visible with this resolution of the spectra.
Figure 5Pathway analysis plot based on serum metabolite profiles of analyses of lesser scaup (Aythya affinis), using the chicken (Gallus gallus) pathway library, showing significantly impacted pathways based on significant VIP metabolites that compare treatment (CORT-implanted) vs. control (placebo-implanted) groups. Only pathways that have impact scores > 0 from pathway topology analysis or significant Holm–Bonferroni adjusted p-values from pathway enrichment analysis are labelled. The diameter of each node corresponds to the impact score, and their colour gradient is related to the p-values (red = highly significant, white = non-significant).